- Home
- RPRX vs NVT Comparison
RPRX vs NVT Comparison
Compare RPRX & NVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | NVT |
|---|---|---|
| Founded | 1996 | 1903 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 25.6B |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | RPRX | NVT |
|---|---|---|
| Price | $57.41 | $165.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 17 |
| Target Price | $65.13 | ★ $206.67 |
| AVG Volume (30 Days) | ★ 2.7M | 1.6M |
| Earning Date | 11-04-2026 | 10-30-2026 |
| Dividend Yield | ★ 1.61% | 0.52% |
| EPS Growth | N/A | ★ 118.78 |
| EPS | 0.71 | ★ 2.18 |
| Revenue | $2,378,193,000.00 | ★ $3,893,100,000.00 |
| Revenue This Year | $47.32 | $40.28 |
| Revenue Next Year | $8.70 | $17.86 |
| P/E Ratio | $82.08 | ★ $74.20 |
| Revenue Growth | 5.06 | ★ 29.51 |
| 52 Week Low | $35.23 | $93.22 |
| 52 Week High | $64.38 | $184.64 |
Technical Indicators
Market Signals| Indicator | RPRX | NVT |
|---|---|---|
| Relative Strength Index (RSI) | 41.62 | 52.49 |
| Support Level | $57.75 | $152.61 |
| Resistance Level | $58.84 | $163.71 |
| Average True Range (ATR) | 1.07 | 4.70 |
| MACD | -0.12 | 0.61 |
| Stochastic Oscillator | 24.51 | 72.35 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About NVT nVent Electric plc
NVent is a leading global provider of electrical connection and protection solutions that touch a broad range of end markets, including infrastructure, industrial, commercial, and residential. NVent designs, manufactures, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. North America accounts for the majority of sales.